Is Cooper Companies (COO) overvalued or fairly valued?

MarketChacha shows Cooper Companies's valuation in context — a forward P/E of about 14.1, a price-to-book of about 1.7 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Cooper Companies (COO)?

Cooper Companies last traded at $70.35 (-0.9% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Cooper Companies

COO · NYSE · Healthcare · United States

$70.35-0.9%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:18 PM

Snapshot

TickerCOO

ExchangeNYSE

SectorHealthcare

IndustryMedical Instruments & Supplies

CountryUnited States

Employees15,000

HeadquartersSan Ramon, United States

Market cap$13.7B

P/B1.7

Volume579.25K

Websitewww.coopercos.com

Filings tracked0

About Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.6%
Institutions99.4%
Public & other0.0%

987 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.8.52%
Vanguard Capital Management LLC6.52%
T. Rowe Price Investment Management, Inc.4.65%
State Street Corporation4.50%
Vanguard Portfolio Management LLC4.47%
Capital World Investors3.80%
Browning West Lp3.58%
Kayne Anderson Rudnick Investment Management LLC3.39%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $1.1B · EPS 1.20

Est. earnings growth +4.1%

Next fiscal year

Rev $4.5B · EPS 5.00

Est. earnings growth +8.1%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$58.8952-wk range$89.83

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about COO

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.